Cargando…
Promoter Methylation of Selected Genes in Non-Small-Cell Lung Cancer Patients and Cell Lines
Specific gene promoter DNA methylation is becoming a powerful epigenetic biomarker in cancer diagnostics. Five genes (CDH1, CDKN2Ap16, RASSF1A, TERT, and WT1) were selected based on their frequently published potential as epigenetic markers. Diagnostic promoter methylation assays were generated base...
Autores principales: | Sarne, Victoria, Huter, Samuel, Braunmueller, Sandrina, Rakob, Lisa, Jacobi, Nico, Kitzwögerer, Melitta, Wiesner, Christoph, Obrist, Peter, Seeboeck, Rita |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7369760/ https://www.ncbi.nlm.nih.gov/pubmed/32605217 http://dx.doi.org/10.3390/ijms21134595 |
Ejemplares similares
-
The Relevance of Gender in Tumor-Influencing Epigenetic Traits
por: Sarne, Victoria, et al.
Publicado: (2019) -
The combinatorial approach of laser-captured microdissection and reverse transcription quantitative polymerase chain reaction accurately determines HER2 status in breast cancer
por: Hofmann, Elisabeth, et al.
Publicado: (2016) -
Current Coverage of the mTOR Pathway by Next-Generation Sequencing Oncology Panels
por: Seeboeck, Rita, et al.
Publicado: (2019) -
ErbB Family Signalling: A Paradigm for Oncogene Addiction and Personalized Oncology
por: Jacobi, Nico, et al.
Publicado: (2017) -
Concentration-Dependent Pro- and Antitumor Activities of Quercetin in Human Melanoma Spheroids: Comparative Analysis of 2D and 3D Cell Culture Models
por: Hundsberger, Harald, et al.
Publicado: (2021)